The development of antiviral drugs has become a critical part of public health efforts, especially in the context of global viral outbreaks. Nations continue adopting diverse strategies to combat viral infections, shaped by differences in scientific infrastructure, regulatory frameworks, economics, and public health priorities. While high-income countries often lead in drug discovery and clinical trials, lower- and middle-income nations contribute through data and innovative approaches. This global perspective shows the importance of international collaboration and equitable access in the development, testing, and distribution of antiviral therapies. Global Perspectives on Antiviral Drug Development explores the global landscape of antiviral drug development, deployment, and management. It offers an in-depth look at how different countries and regions around the world tackle viral threats, with a strong emphasis on the strategies that shape public health and the innovations driving the future of antiviral treatments. This book covers topics such as vaccines, pharmacology, and personalized medicine, and is a useful resource for medical and healthcare professionals, engineers, academicians, researchers, and scientists.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Bancha Yingngam is working as Associate Professor (Pharmaceutical Sciences and Technology) in the Faculty of Pharmaceutical Sciences at Ubon Ratchathani University, Ubon Ratchathani, Thailand. He received his B.Pharm. and Ph.D. (Pharmaceutical Sciences) at the Ubon Ratchathani, and postdoctoral fellowship at Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria. His areas of interest include artificial intelligence, optimization methods, green chemistry, natural product chemistry, cosmeceuticals, and pharmaceutical nanotechnology. He has authored and co-authored many scientific papers published in international journals, and proceedings of international and national scientific conferences. He has also authored more than 30 book chapters and edited three textbooks.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9798369392768
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 50356918-n
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9798369392768
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 50356918-n
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 50356918
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 50356918
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Hardcover. Etat : new. Hardcover. The development of antiviral drugs has become a critical part of public health efforts, especially in the context of global viral outbreaks. Nations continue adopting diverse strategies to combat viral infections, shaped by differences in scientific infrastructure, regulatory frameworks, economics, and public health priorities. While high-income countries often lead in drug discovery and clinical trials, lower- and middle-income nations contribute through data and innovative approaches. This global perspective shows the importance of international collaboration and equitable access in the development, testing, and distribution of antiviral therapies. Global Perspectives on Antiviral Drug Development explores the global landscape of antiviral drug development, deployment, and management. It offers an in-depth look at how different countries and regions around the world tackle viral threats, with a strong emphasis on the strategies that shape public health and the innovations driving the future of antiviral treatments. This book covers topics such as vaccines, pharmacology, and personalized medicine, and is a useful resource for medical and healthcare professionals, engineers, academicians, researchers, and scientists. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798369392768
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Buch. Etat : Neu. Global Perspectives on Antiviral Drug Development | Muhammad Shahzad Aslam (u. a.) | Buch | Englisch | 2025 | IGI Global | EAN 9798369392768 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 133466030
Quantité disponible : 5 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The development of antiviral drugs has become a critical part of public health efforts, especially in the context of global viral outbreaks. Nations continue adopting diverse strategies to combat viral infections, shaped by differences in scientific infrastructure, regulatory frameworks, economics, and public health priorities. While high-income countries often lead in drug discovery and clinical trials, lower- and middle-income nations contribute through data and innovative approaches. This global perspective shows the importance of international collaboration and equitable access in the development, testing, and distribution of antiviral therapies. Global Perspectives on Antiviral Drug Development explores the global landscape of antiviral drug development, deployment, and management. It offers an in-depth look at how different countries and regions around the world tackle viral threats, with a strong emphasis on the strategies that shape public health and the innovations driving the future of antiviral treatments. This book covers topics such as vaccines, pharmacology, and personalized medicine, and is a useful resource for medical and healthcare professionals, engineers, academicians, researchers, and scientists. N° de réf. du vendeur 9798369392768
Quantité disponible : 1 disponible(s)